Patients Will Not Benefit From Select Committee Recommendations On NICE, Says ABPI, UK
Jan 12th 2008Drug InformationPharma Industry
Patients will see little benefit in their access to modern, innovative medicines if the recommendations of the House of Commons Health Select Committee are put into effect, the Association of the British Pharmaceutical Industry (ABPI) said.For the first time, a formal report has acknowledged that the National Institute for Health and Clinical Excellence (NICE) is a body set up to enforce the rationing of medicines.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
